273 related articles for article (PubMed ID: 24720440)
21. Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.
Blaise S; Roustit M; Forli A; Imbert B; Cracowski JL
Int Wound J; 2017 Dec; 14(6):978-981. PubMed ID: 28303689
[TBL] [Abstract][Full Text] [Related]
22. Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.
Taniguchi T; Asano Y; Hatano M; Tamaki Z; Tomita M; Kawashima T; Miyazaki M; Sumida H; Akamata K; Takahashi T; Ichimura Y; Toyama T; Sugita M; Noda S; Yao A; Kinugawa K; Sato S
Br J Dermatol; 2012 Feb; 166(2):417-21. PubMed ID: 21848685
[TBL] [Abstract][Full Text] [Related]
23. Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.
Cestelli V; Manfredi A; Sebastiani M; Praino E; Cannarile F; Giuggioli D; Ferri C
Mod Rheumatol; 2017 Jan; 27(1):110-114. PubMed ID: 27310203
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of bosentan in the treatment of Raynaud's phenomenon in patients with systemic sclerosis never treated with prostanoids.
Parisi S; Bruzzone M; Centanaro Di Vittorio C; Laganà A; Peroni CL; Fusaro E
Reumatismo; 2014 Mar; 65(6):286-91. PubMed ID: 24705032
[TBL] [Abstract][Full Text] [Related]
25. Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan.
Meijs J; Voskuyl AE; Bloemsaat-Minekus JP; Vonk MC
Rheumatology (Oxford); 2015 Feb; 54(2):262-9. PubMed ID: 25150178
[TBL] [Abstract][Full Text] [Related]
26. Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.
Ngcozana T; Ong V; Denton CP
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24682137
[TBL] [Abstract][Full Text] [Related]
27. Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial.
Kuhn A; Haust M; Ruland V; Weber R; Verde P; Felder G; Ohmann C; Gensch K; Ruzicka T
Rheumatology (Oxford); 2010 Jul; 49(7):1336-45. PubMed ID: 20371505
[TBL] [Abstract][Full Text] [Related]
28. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
Launay D; Diot E; Pasquier E; Mouthon L; Boullanger N; Fain O; Jego P; Carpentier P; Hatron PY; Hachulla E
Presse Med; 2006 Apr; 35(4 Pt 1):587-92. PubMed ID: 16614599
[TBL] [Abstract][Full Text] [Related]
29. Digital ulcers and outcomes assessment in scleroderma.
Matucci-Cerinic M; Seibold JR
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v46-7. PubMed ID: 18784143
[TBL] [Abstract][Full Text] [Related]
30. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
[TBL] [Abstract][Full Text] [Related]
31. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
32. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis.
Bruni C; Guiducci S; Bellando-Randone S; Lepri G; Braschi F; Fiori G; Bartoli F; Peruzzi F; Blagojevic J; Matucci-Cerinic M
Rheumatology (Oxford); 2015 Jan; 54(1):72-6. PubMed ID: 25065009
[TBL] [Abstract][Full Text] [Related]
33. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors.
Sunderkötter C; Herrgott I; Brückner C; Moinzadeh P; Pfeiffer C; Gerss J; Hunzelmann N; Böhm M; Krieg T; Müller-Ladner U; Genth E; Schulze-Lohoff E; Meurer M; Melchers I; Riemekasten G;
Br J Dermatol; 2009 Apr; 160(4):835-43. PubMed ID: 19183180
[TBL] [Abstract][Full Text] [Related]
34. Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients.
García de la Peña-Lefebvre P; Rodríguez Rubio S; Valero Expósito M; Carmona L; Gámir Gámir ML; Beltrán Gutiérrez J; Díaz-Miguel C; Orte Martínez J; Zea Mendoza AC
Rheumatology (Oxford); 2008 Apr; 47(4):464-6. PubMed ID: 18263597
[TBL] [Abstract][Full Text] [Related]
35. Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease.
Romaniello A; Gigante A; Di Paolo M; Tallerini G; Barbano B; Amoroso D; Palange P; Rosato E
Int J Cardiol; 2016 Nov; 223():113-115. PubMed ID: 27537734
[No Abstract] [Full Text] [Related]
36. The safety and persistence of intravenous iloprost in systemic sclerosis.
Martins P; Dourado E; Fonseca JE; Romão V; Resende C
ARP Rheumatol; 2022; 1(2):122-128. PubMed ID: 35810370
[TBL] [Abstract][Full Text] [Related]
37. Effect of a sequential therapy of bosentan and iloprost versus a monotherapy with bosentan in the treatment of scleroderma related digital ulcers.
Hafner F; Thomas G; Froehlich H; Steidl K; Brodmann M
Int Angiol; 2011 Oct; 30(5):493-5. PubMed ID: 21804491
[No Abstract] [Full Text] [Related]
38. A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis.
Chang SH; Jun JB; Lee YJ; Kang TY; Moon KW; Ju JH; Kang SW; Choi IA; Park YB; Lee SG; Lee SS; Heo NH; Lee EB
Rheumatology (Oxford); 2021 Dec; 60(12):5814-5819. PubMed ID: 33576774
[TBL] [Abstract][Full Text] [Related]
39. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
[TBL] [Abstract][Full Text] [Related]
40. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.
Nihtyanova SI; Brough GM; Black CM; Denton CP
Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
